Monogram Cash Ratio vs Change In Cash Analysis
| MGRM Stock | 1.97 0.01 0.51% |
Monogram Orthopaedics financial indicator trend analysis is infinitely more than just investigating Monogram Orthopaedics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Monogram Orthopaedics is a good investment. Please check the relationship between Monogram Orthopaedics Cash Ratio and its Change In Cash accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Monogram Orthopaedics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Cash Ratio vs Change In Cash
Cash Ratio vs Change In Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Monogram Orthopaedics Cash Ratio account and Change In Cash. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Monogram Orthopaedics' Cash Ratio and Change In Cash is -0.37. Overlapping area represents the amount of variation of Cash Ratio that can explain the historical movement of Change In Cash in the same time period over historical financial statements of Monogram Orthopaedics Common, assuming nothing else is changed. The correlation between historical values of Monogram Orthopaedics' Cash Ratio and Change In Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash Ratio of Monogram Orthopaedics Common are associated (or correlated) with its Change In Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change In Cash has no effect on the direction of Cash Ratio i.e., Monogram Orthopaedics' Cash Ratio and Change In Cash go up and down completely randomly.
Correlation Coefficient | -0.37 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Cash Ratio
Change In Cash
Most indicators from Monogram Orthopaedics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Monogram Orthopaedics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Monogram Orthopaedics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. As of the 22nd of November 2024, Selling General Administrative is likely to grow to about 4.3 M, while Issuance Of Capital Stock is likely to drop about 12.3 M.
| 2021 | 2023 | 2024 (projected) | Interest Expense | 21.7K | 19.5K | 18.5K | Depreciation And Amortization | 322.0K | 412.3K | 433.0K |
Monogram Orthopaedics fundamental ratios Correlations
Click cells to compare fundamentals
Monogram Orthopaedics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Monogram Orthopaedics fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 2.6M | 8.1M | 8.7M | 13.7M | 16.6M | 17.4M | |
| Short Long Term Debt Total | 2.1M | 205.5K | 211.5K | 610.2K | 492.0K | 777.0K | |
| Other Current Liab | 229.2K | 2.7M | 4.6M | 8.3M | 227.7K | 216.3K | |
| Total Current Liabilities | 2.8M | 3.0M | 5.1M | 9.0M | 2.8M | 4.0M | |
| Total Stockholder Equity | (274.6K) | 5.0M | 3.5M | 4.1M | 13.4M | 14.1M | |
| Property Plant And Equipment Net | 235.7K | 989.3K | 695.2K | 1.1M | 1.4M | 765.2K | |
| Net Debt | (195.4K) | (5.4M) | (5.3M) | (9.9M) | (13.1M) | (12.4M) | |
| Retained Earnings | (3.2M) | (12.3M) | (24.1M) | (37.8M) | (51.5M) | (48.9M) | |
| Accounts Payable | 250.4K | 182.8K | 449.0K | 663.2K | 2.5M | 2.6M | |
| Cash | 2.3M | 5.6M | 5.5M | 10.5M | 13.6M | 14.3M | |
| Non Current Assets Total | 235.7K | 1.7M | 2.2M | 2.4M | 2.0M | 1.4M | |
| Cash And Short Term Investments | 2.3M | 5.6M | 5.5M | 10.5M | 13.6M | 14.3M | |
| Liabilities And Stockholders Equity | 2.6M | 8.1M | 8.7M | 13.7M | 16.6M | 17.4M | |
| Non Current Liabilities Total | 48K | 147.9K | 118.6K | 492.0K | 363.7K | 274.0K | |
| Other Stockholder Equity | 2.9M | 17.2M | 27.6M | 41.9M | 64.9M | 68.1M | |
| Total Liab | 2.9M | 3.1M | 5.2M | 9.5M | 3.2M | 4.3M | |
| Total Current Assets | 2.4M | 6.4M | 6.5M | 11.3M | 14.6M | 15.3M | |
| Short Term Debt | 2.1M | 57.5K | 92.9K | 118.2K | 128.3K | 121.9K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Monogram Orthopaedics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monogram Orthopaedics. If investors know Monogram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monogram Orthopaedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.012 | Return On Assets (0.61) | Return On Equity (1.22) |
The market value of Monogram Orthopaedics is measured differently than its book value, which is the value of Monogram that is recorded on the company's balance sheet. Investors also form their own opinion of Monogram Orthopaedics' value that differs from its market value or its book value, called intrinsic value, which is Monogram Orthopaedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monogram Orthopaedics' market value can be influenced by many factors that don't directly affect Monogram Orthopaedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monogram Orthopaedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Monogram Orthopaedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monogram Orthopaedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.